Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Money raise coming soon?
View:
Post by newdaydawning on Jun 26, 2022 2:07pm

Money raise coming soon?

Anyone know anything?
Comment by enriquesuave on Jun 26, 2022 2:18pm
Just a hunch, but they have enough $ to keep operating until BTD and Partnership with enough cash until Buy out. IMHO. Time will tell unless they do a small-medium raise?
Comment by 99942Apophis on Jun 26, 2022 2:42pm
enriquesuave wrote Just a hunch, but they have enough $ to keep operating until BTD and Partnership with enough cash until Buy out. IMHO. Time will tell unless they do a small-medium raise? Thinking along the lines of first year commercialization could mean 500M to over 1B in sales of course that would quickly grow in following years. A partnership might be done in a number of forms and in my ...more  
Comment by Longholder99 on Jun 26, 2022 2:45pm
Here we go with this again. Must be good news coming soon. The financing topic always comes up to try and shake up weak.hands. Like a clock this is. Every time Theralase makes a step fwd. Funny!
Comment by StevenBirch on Jun 26, 2022 3:41pm
Yeah, that one made my day.
Comment by skys1 on Jun 26, 2022 3:43pm
"Money raise coming soon", is pure nonsense! How many times does management have to tell you they have enough funds toget them through the Ph 2 process before you will believe them? Plus recently they have gotten additional revenue from the exercise of warrants and now they are hiring additional high level people with appropriate salaries. That wouldn't imply a cash need. In the next ...more  
Comment by langosta on Jun 26, 2022 5:31pm
Yeah, about as subtle as a kick in the testaments.  
Comment by Longholder99 on Jun 27, 2022 1:15pm
Ya we know theres no money raise coming as the company cashed up for Ph2 completion a long time ago. But the bottom feeders domt want newbie investors to know this and throw this nugget out usually right before the company releases positive news. Thats what most of us know.. .there are no guarantees on the Venture. Do your own DD folks. IMO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250